| De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients H Kaneku, JG O’leary, N Banuelos, LW Jennings, BM Susskind, ... American Journal of Transplantation 13 (6), 1541-1548, 2013 | 274 | 2013 |
| Abrogation of anti-HLA antibodies via proteasome inhibition HL Trivedi, PI Terasaki, A Feroz, MJ Everly, AV Vanikar, V Shankar, ... Transplantation 87 (10), 1555-1561, 2009 | 203 | 2009 |
| High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant JG O’Leary, H Kaneku, BM Susskind, LW Jennings, MA Neri, GL Davis, ... American Journal of Transplantation 11 (9), 1868-1876, 2011 | 179 | 2011 |
| Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation JG O’Leary, H Kaneku, N Banuelos, LW Jennings, GB Klintmalm, ... American Journal of Transplantation 15 (4), 1003-1013, 2015 | 153 | 2015 |
| Preformed class II donor‐specific antibodies are associated with an increased risk of early rejection after liver transplantation JG O'Leary, H Kaneku, LW Jennings, N Bañuelos, BM Susskind, ... Liver Transplantation 19 (9), 973-980, 2013 | 138 | 2013 |
| Donor‐specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation H Kaneku, JG O'Leary, M Taniguchi, BM Susskind, PI Terasaki, ... Liver Transplantation 18 (8), 984-992, 2012 | 134 | 2012 |
| Antibody‐mediated rejection as a contributor to previously unexplained early liver allograft loss JG O'Leary, H Kaneku, AJ Demetris, JD Marr, SM Shiller, BM Susskind, ... Liver transplantation 20 (2), 218-227, 2014 | 122 | 2014 |
| Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts JG O’Leary, J Cai, R Freeman, N Banuelos, B Hart, M Johnson, ... American Journal of Transplantation 16 (2), 603-614, 2016 | 112 | 2016 |
| Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry. HK Kaneku, PI Terasaki Clinical transplants, 1-27, 2006 | 85 | 2006 |
| Acute liver allograft antibody‐mediated rejection: an inter‐institutional study of significant histopathological features JG O'Leary, S Michelle Shiller, C Bellamy, MA Nalesnik, H Kaneku, ... Liver transplantation 20 (10), 1244-1255, 2014 | 79 | 2014 |
| Prevalence and clinical impact of donor-specific alloantibody among intestinal transplant recipients EY Cheng, MJ Everly, H Kaneku, N Banuelos, LJ Wozniak, RS Venick, ... Transplantation 101 (4), 873-882, 2017 | 73 | 2017 |
| Antibodies to HLA-E in Nonalloimmunized Males: Pattern of HLA-Ia Reactivity of Anti–HLA-E–Positive Sera MH Ravindranath, H Kaneku, N El-Awar, LE Morales-Buenrostro, ... The Journal of Immunology 185 (3), 1935-1948, 2010 | 70 | 2010 |
| Donor-specific HLA antibodies in living versus deceased donor liver transplant recipients J Levitsky, H Kaneku, C Jie, RC Walsh, M Abecassis, AR Tambur American Journal of Transplantation 16 (8), 2437-2444, 2016 | 64 | 2016 |
| Donor‐specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients JG O'Leary, H Kaneku, L Jennings, BM Susskind, PI Terasaki, ... Liver Transplantation 20 (6), 655-663, 2014 | 64 | 2014 |
| HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies MH Ravindranath, M Taniguchi, C Chen, M Ozawa, H Kaneku, N El-Awar, ... Molecular immunology 47 (5), 1121-1131, 2010 | 56 | 2010 |
| Using donor-specific antibodies to monitor the need for immunosuppression J Hoshino, H Kaneku, MJ Everly, S Greenland, PI Terasaki Transplantation 93 (11), 1173-1178, 2012 | 48 | 2012 |
| Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies MH Ravindranath, T Pham, N El-Awar, H Kaneku, PI Terasaki Molecular immunology 48 (4), 423-430, 2011 | 47 | 2011 |
| Protective immunity remains intact after antibody removal by means of proteasome inhibition MJ Everly, PI Terasaki, J Hopfield, HL Trivedi, H Kaneku Transplantation 90 (12), 1493-1498, 2010 | 45 | 2010 |
| Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients HL Trivedi, PI Terasaki, A Feroz, AV Vanikar, VB Trivedi, ... Transplantation 90 (2), 221-222, 2010 | 41 | 2010 |
| Elimination of post-transplant donor-specific HLA antibodies with bortezomib. A Idica, H Kaneku, MJ Everly, HL Trivedi, A Feroz, AV Vanikar, V Shankar, ... Clinical transplants, 229-239, 2008 | 41 | 2008 |
